Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone and Extracellular Adenosine Formation
NCT01837108Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute myocardial infarction (AMI) comparing Placebo with Eplerenone (2 arms). Primary endpoint: Forearm blood flow response at 8 days. Started Apr 2013; status: completed.
02
Drugs
eplerenone
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01837108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837108.